| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,981 |
1,549 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,984 |
1,727 |
$881.36 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
340 |
335 |
$150.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,188 |
1,166 |
$1.45 |
| 80053 |
Comprehensive metabolic panel |
1,118 |
1,066 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,712 |
3,382 |
$0.00 |
| 86593 |
|
285 |
283 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
581 |
547 |
$0.00 |
| 4450F |
|
296 |
290 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,292 |
2,263 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
434 |
433 |
$0.00 |
| 85027 |
|
1,240 |
1,223 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,012 |
1,004 |
$0.00 |
| 82043 |
|
451 |
440 |
$0.00 |
| 94760 |
|
12 |
12 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
287 |
275 |
$0.00 |
| 1220F |
|
306 |
303 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
226 |
225 |
$0.00 |
| 3074F |
|
225 |
194 |
$0.00 |
| 90686 |
|
44 |
44 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
32 |
32 |
$0.00 |
| 82607 |
|
76 |
75 |
$0.00 |
| 1111F |
|
71 |
64 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
29 |
29 |
$0.00 |
| 3044F |
|
41 |
41 |
$0.00 |
| 81001 |
|
59 |
58 |
$0.00 |
| 99443 |
|
38 |
37 |
$0.00 |
| 86592 |
|
29 |
29 |
$0.00 |
| 3075F |
|
41 |
39 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
13 |
12 |
$0.00 |
| 99441 |
|
25 |
25 |
$0.00 |
| 84450 |
|
705 |
697 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
226 |
225 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$0.00 |
| 82540 |
|
451 |
440 |
$0.00 |
| 80061 |
Lipid panel |
1,844 |
1,829 |
$0.00 |
| 84439 |
|
370 |
368 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
86 |
85 |
$0.00 |
| 86703 |
|
539 |
536 |
$0.00 |
| 82947 |
|
562 |
556 |
$0.00 |
| 82274 |
|
117 |
117 |
$0.00 |
| 99442 |
|
678 |
641 |
$0.00 |
| 84460 |
|
204 |
204 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13 |
13 |
$0.00 |
| 90658 |
|
40 |
40 |
$0.00 |
| 3078F |
|
251 |
218 |
$0.00 |
| 81003 |
|
24 |
24 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
55 |
30 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14 |
13 |
$0.00 |